Market closed
GRAIL/$GRAL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GRAIL
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Ticker
$GRAL
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
1,000
Website
GRAIL Metrics
BasicAdvanced
$912M
-
-$63.54
-
-
Price and volume
Market cap
$912M
52-week high
$63.99
52-week low
$12.33
Average daily volume
1.9M
Financial strength
Current ratio
10.658
Quick ratio
10.189
Long term debt to equity
2.192
Total debt to equity
2.722
Management effectiveness
Return on assets (TTM)
-13.92%
Return on equity (TTM)
-65.92%
Valuation
Price to revenue (TTM)
6.838
Price to book
0.36
Price to tangible book (TTM)
1.88
Price to free cash flow (TTM)
-1.475
Growth
Revenue change (TTM)
34.90%
Earnings per share change (TTM)
34.59%
3-year revenue growth (CAGR)
104.84%
What the Analysts think about GRAIL
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for GRAIL stock.
GRAIL Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
GRAIL Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
GRAIL News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for GRAIL stock?
GRAIL (GRAL) has a market cap of $912M as of March 14, 2025.
What is the P/E ratio for GRAIL stock?
The price to earnings (P/E) ratio for GRAIL (GRAL) stock is 0 as of March 14, 2025.
Does GRAIL stock pay dividends?
No, GRAIL (GRAL) stock does not pay dividends to its shareholders as of March 14, 2025.
When is the next GRAIL dividend payment date?
GRAIL (GRAL) stock does not pay dividends to its shareholders.
What is the beta indicator for GRAIL?
GRAIL (GRAL) does not currently have a Beta indicator.